Abstract
Embryonic development is orchestrated by robust and complex regulatory mechanisms acting at different scales of organization. In vivo studies are particularly challenging for mammals after implantation, owing to the small size and inaccessibility of the embryo. The generation of stem cell models of the embryo represents a powerful system with which to dissect this complexity. Control of geometry, modulation of the physical environment, and priming with chemical signals reveal the intrinsic capacity of embryonic stem cells to make patterns. Adding the stem cells for the extraembryonic lineages generates three-dimensional models that are more autonomous from the environment and recapitulate many features of the pre- and postimplantation mouse embryo, including gastrulation. Here, we review the principles of self-organization and how they set cells in motion to create an embryo.
Vertebrate development deploys orthologous sets of genes that first create the body axesanterior-posterior (AP), dorsal-ventral (DV), and left-right (LR)as well as the germ layersendoderm, mesoderm, and ectodermand ultimately refines these patterns to the diverse adult forms we know. How are these spectacular feats of self-organization possible?
Although we have an inventory of genes that confer cell identity, we are far from understanding how their products communicate to generate embryonic patterns.
Multiple levels of regulation add robustness to embryonic development, but this redundancy makes the regulatory network difficult to decipher. Using stem cells as a model system to study embryology, we are now able to start peeling back these layers of regulation to reveal the dynamic organization of the embryo. Technical advances that created stem cell embryology were reviewed in (1). Here we focus on the principles of how cell communication at the molecular level enables embryonic self-organization in mouse and human embryos.
Preimplantation development is fairly conserved among mammalian species (2). Fertilization leads to a stepwise process of cell fate specification that culminates with the blastocyst comprising three cell types: the embryonic epiblast and the extraembryonic primitive endoderm and trophectoderm (36). Blastocyst implantation initiates a dialogue between the uterus and the embryo, which leads to the reorganization of both the embryo and the maternal tissues. Across diverse mammalian species, the basic relation between tissues is conserved, but postimplantation conceptuses present distinct embryonic architectures, from the cylinder-like shape of mouse embryos to the bilaminar disc of human embryos (2) (Fig. 1). How these different shapes evolved remains unknown.
Extraembryonic tissues are shown in different shades of teal, and epiblast derivatives in different shades of red. EPI, epiblast; TE, trophectoderm; PE, primitive endoderm (mouse), HYPO, hypoblast (human); ExE, extraembryonic ectoderm; VE, visceral endoderm; AVE, anterior visceral endoderm; CT, cytotrophoblast; SCT, syncytiotrophoblast; YSE, yolk sac endoderm.
Interactions between embryonic and extraembryonic tissues are critical to reshaping the developing embryo. In the mouse, the polar trophectoderm proliferates in response to fibroblast growth factor 4 (FGF4) secreted by the epiblast to form the extraembryonic ectoderm (7), which will form the placenta. Concomitantly, the epiblast and extraembryonic ectoderm undergo a process of lumenogenesis in response to extracellular matrix (ECM) secreted by the primitive endodermderived visceral endoderm (8, 9). The fusion of the extraembryonic ectoderm and epiblast cavities leads to the formation of the proamniotic cavity (10), fundamental for the establishment of the body plan. This coincides with a symmetry-breaking event to form the anterior signaling center in the visceral endoderm (AVE) that defines the AP axis and the site of gastrulation (1113).
In human embryos, the epiblast undergoes lumenogenesis in a similar way to that of the mouse, with one important difference: Epiblast in contact with the trophoblast forms the amniotic epithelium, whereas epiblast in contact with the hypoblast (visceral endoderm-equivalent) forms the epiblast disc (1, 2, 14). The mechanisms of symmetry breaking leading to AP axis formation in human embryos remain unknown, but mechanical and chemical cues are clearly involved. In cynomolgus monkey embryos, a population of hypoblast cells that expresses Wnt and Nodal inhibitors (DKK1 and CER1), characteristic of the mouse AVE, has been identified (15).
Is a dialogue between mother and embryo required for this morphogenesis? Comparative embryology provides a preliminary answer. In mammalian embryos such as pig, rabbit, and cow, embryonic morphogenesis and gastrulation take place before implantation (16, 17). Mouse and human embryos can undergo early postimplantation morphogenesis without maternal input (8, 1821). Even if the uterine environment could help to modulate these events (22, 23), the self-organizing capabilities of mammalian embryos (and stem cells) are becoming increasingly apparent.
Although a system composed of invariant parts might be induced to self-assemble, here we focus mainly on self-organization that encompasses both patterning (fate change) by exchange of signals, as well as cell rearrangements. To further refine terminology, consider a supersaturated vapor that is spatially homogeneous until droplets nucleate and grow. The immediate trigger for a drop may be a speck of dust, but its subsequent expansion is reproducible. This is an example of spontaneous symmetry breaking, because the initially homogeneous vapor (the symmetric state) becomes an inhomogeneous mist of droplets. Analogous, self-organization occurs in systems of chemical reactions with diffusion where Turing showed that inhomogeneities with a characteristic spatial scale result from a random trigger to a uniform but unstable system (24). Embryology generally avoids spontaneous symmetry breaking because the outcome is too fragile; rather, it proceeds by progressive refinement of prior asymmetries, still suggestive of Turings ideas.
The requirements for Turing instability are intuitively transparent: An activator induces the production of its own inhibitor, but the inhibitor diffuses more rapidly than the activator and confines the activator in space. This has the seemingly paradoxical consequence that the peak expression of both the activator and inhibitor are in the same place, rather than being opposed. Both modes of regulation are seen in the mouse embryo (25).
Because signaling pathways often involve secreted inhibitors, Turing phenomena are frequently posited. However, there are many confounding influences as exemplified by studies of digits and feather follicles in the skin (2628). Reaction-diffusion systems can also account for the community effect, articulated by John Gurdon, whereby a tissue forces the majority fate on cells within it (2931).
In quantitative analogy to the surface tensiondriven separation of oil and water, cells of different types can sort by differential adhesion (32). Chemotaxis can also contribute to pattern formation as in sporulation in Dictyostelium, and signaling pathways themselves can provide chemotactic signals (33).
The disc shape of the human epiblast suggests the possibility of a two-dimensional (2D) model. Embryonic stem cells (ESCs) naturally supply the epiblast. The extraembryonic hypoblast and spatial confinement are modeled by micropatterns: Slides with arrays of disks where ECM proteins bind and control where cells adhere. The extraembryonic trophoblast is modeled by addition of BMP4 to the media to provide the morphogen trigger (34). As envisioned by Tam (35), the cells pattern with concentric rings of endoderm and mesoderm and a central disk of anterior epiblast (Figs. 2 and 3). The mesendoderm cells express the same markers and require the same signals (Wnt and Activin/Nodal induced downstream of BMP4) as does the mouse primitive streak, and the same secreted inhibitors are required to spatially confine the streak and shield the central epiblast from morphogens. Thus, a homogeneous layer of human ESCs (hESCs) can self-pattern on a scale of ~2000 cells, without contribution from extraembryonic lineages. Similarly, micropattern culture guides self-organization of ectodermal derivatives (36).
Oct4 labels pluripotent epiblast cells; Brachyury marks mesoderm; Gata6 marks endoderm; Gata3 marks extraembryonic cells; Sox2 labels both ectoderm and pluripotent cells; 7xTCF-mCherry is a reporter of Wnt signaling activity; E-Cadherin labels cell-cell adhesion sites; and Dapi and Hoechst label nuclei. ESCs, embryonic stem cells; TSCs, trophoblast stem cells. Scale bars, 100 m. These models are described in (34, 50, 52, 53, 5659, 61).
For each model, the starting cell types, the corresponding embryonic stage, and the main advantages and disadvantages are shown. AVE, anterior visceral endoderm; EMT, epithelial-to-mesenchymal transition; PASE, postimplantation amniotic sac embryoid; ESCs, embryonic stem cells; TSCs, trophoblast stem cells; XEN cells, extraembryonic endoderm stem cells.
The micropattern system facilitates deciphering how cell fates are defined by distance from the colony boundary (3740). hESCs are apicobasally polarized, and the BMP, Activin, and Nodal receptors are basolateral and not accessible to apical ligands except at the colony boundary. The secreted BMP inhibitor NOGGIN also restricts signaling to the colony boundary and is active from the apical side, suggesting complex signal transmission in polarized epithelia (41).
Receptor localization in the micropattern system, when folded into a cup-shape as in the mouse, helps explain why the proamniotic cavity (facing the apical side of the epiblast) does not short-circuit the proximal-distal patterning and why the initial BMP response is proximal only (41). This conjecture was confirmed by mistargeting the BMP receptors in the embryo (42).
Micropattern culture has been extended to the mouse (43). When mouse ESCs (mESCs) are differentiated to a postimplantation-like state (44) and transferred to micropatterns, they display properties similar to those of the pregastrulation epiblast. Differentiation with Wnt, Activin and BMP gives fates indicative of distal versus proximal streak derivatives.
Embryonic and extraembryonic stem cells have been shown to self-organize in 3D culture (4549). When ESCs are cultured in a 3D gel supplemented with ECM, they form an apicalbasal polarized shell that eliminates the boundaries of micropattern culture, allowing control of substrate mechanics and chemistry. Human pluripotent cells cultured in such a system respond to BMP by polarizing and breaking symmetry into anterior epiblast and posterior primitive streak in a Wnt-dependent manner (50).
A synthesis of signals and mechanics can be achieved by placing hESCs on a 3D soft gel and doping the media above with a low concentration of ECM components (51, 52). This treatment induces the patches to fold into closed polarized shells, which, depending on the initial cell density, can generate squamous, asymmetric, or columnar cysts. Squamous cysts represent an amnion-like tissue based on gene expression, cell shape, and BMP signaling activity (51), also active in the amnion of cynomolgous monkeys (15). Columnar cysts represent the epiblast, and asymmetric cysts undergo a symmetry-breaking event to form an amnion-like hemisphere and an epithelia-like disc (Figs. 2 and 3). The morphogenesis of the resulting amniotic sac plausibly requires BMP that induces Brachyury expression and EMT in the putative epiblast, but the mechanisms of symmetry breaking remain unknown. With the ability to define a gel surface in 3D, future studies will shed light on how morphology influences cell-cell signaling.
Embryoid bodies offer an alternative approach for eliciting the self-organizing potential of stem cells (53, 54). When a clump of mESCs is given a pulse of Wnt agonist, it elongates into a tube showing markers for AP, DV, and LR axes (55, 56) (Fig. 2). These so-called gastruloids recapitulate the spatiotemporal patterns of gene expression of embryos after gastrulation, such as homeobox (HOX) genes, in the correct temporal order and in nested telescoping domains (57).
These ESC-only based models are informative in revealing how homogeneous populations of cells can give rise to different cellular fates through the process of self-organization. However, these models differ from those of natural embryos in their lack of extraembryonic tissues, which are critical for development and provide spatial context for signaling interactions. For this reason, new stem cell embryo models have been developed that incorporate interactions of ESCs with extraembryonic cells (5861) (Figs. 2 and 3).
Combining mESCs and trophoblast stem cells (TSCs) (Fig. 1) in ECM (58) to substitute for the basal membrane produced by the primitive endoderm leads to the generation of postimplantation embryo-like structures. In this model, cells polarize and form lumens in the ESC-derived embryonic and TSC-derived extraembryonic compartments that then join, in response to Nodal signaling (58, 60). A domain of asymmetric Brachyury expression develops at the boundary between the ESC and TSC compartments. These polarized embryo-like structures induce mesoderm formation but do not proceed through gastrulation (Figs. 2 and 3). This event has been observed after substituting the ECM with the third stem cell type, extraembryonic endoderm (XEN) stem cells (Fig. 1), which provide the natural basement membrane (59, 60). As a result, the formed structures look markedly similar to early postimplantation embryos in morphology, gene expression, and signaling communication. They break symmetry at the embryonic and extraembryonic boundary with the induction of AP patterning and EMT, leading to mesoderm and definitive endoderm formation (59). This self-organization occurs in response to BMP and Wnt signaling active during the cavity fusion process (58, 59). Finally, the markers of primordial germ cells become expressed in a spatial-temporal manner characteristic of development. These structures induce decidualization upon their transfer to mouse foster mothers but do not develop further.
The self-assembly and subsequent self-organization into so-called gastrulating embryo-like structures are possible because the different stem cell types not only establish signaling among themselves but also provide the building blocks for spatial morphogenesis. The migration of ESCs to form the mesoderm layer, sandwiched between ESC-derived epiblast and XEN-derived visceral endoderm, and replacement of the XEN-layer with definitive endoderm are the hallmarks of early-to-mid gastrulation (59). This points to the essential requirement for the correct choreography of cells from embryonic and the two extraembryonic tissues to achieve correct form.
Will stem cell models ever pass the ultimate test of function, which is development following implantation? Combining mESCs and TSCs in a nonadherent platform leads to the generation of preimplantation embryo-like structures markedly similar to blastocysts, both in terms of shape, gene expression, and intercellular communication (61) (Fig. 2). These so-called blastoids can also induce decidualization, but then their development stops (Fig. 3). The derivation of extraembryonic stem cells that better match the expression signatures of real embryos should improve the morphology of these embryo-like structures (62, 63). Similarly, the recent generation of expanded potential stem cells, which have the ability to form both embryonic and extraembryonic tissues, represents a promising tool for future research (64, 65)
Stem cell models of embryogenesis allow independent control of shape, mechanics, and means to juxtapose embryonic and extraembryonic tissues. Therefore, they represent powerful systems with which to address classic questions of embryology. For example, does gastrulation proceed in embryo-like structures of anomalous size, or does size have to be regulated first? Which combination of chemical and mechanical signals suffices to trigger primitive streak formation? To what extent can we induce gastrulation without AVE? Do the genetic barriers to chimerism operate through the same pathways as intraspecies cell competition? Stem cell systems will thus illuminate the genetic determinates of size and timing control.
Stem cellderived embryos are models of development, and therefore they cannot fully recreate all the complexity of developing organisms. The field of stem cell embryology is in its infancy and will expand by tuning chemical and physical parameters, and using stem cell lines with broader developmental potential (64, 65). Particularly interesting would be the combination of hESCs with human TSCs (66), and potentially human hypoblast stem cells, to recapitulate the human conceptus.
However, in devising these studies, it is important to consider when stem cell models of embryos acquire the protections attached to human embryos. Is a collection of cells that mimics gastrulation any more human than a brain organoid that might one day be endowed with sensory primordia (67)? It is clearly unethical to implant a stem cellderived embryo into a human, yet many pregnancies fail or are impaired by placentation. Can stem cell models help to address this problem?
The promise for basic science is clear. Building embryos from stem cells, like the in vitro reconstitution of biochemical systems from purified components, is the test of whether we can understand the whole from the parts.
We are grateful to N. Rivron, B. Sozen, D. Turner, A. Martinez-Arias, J. Fu, M. Simunovic, A. Yoney, R. Nusse, D. ten Berge, and W. Koole for providing images for Fig. 2.
M.N.S received funding from an Early Career Leverhulme Trust fellowship and an Advanced EMBO fellowship. Work in the laboratory of M.Z-G. is funded by the Wellcome Trust (207415/Z/17/Z) and the European Research Council (ERC grant 669198). Work of E.D.S. is funded by NIH grant GM101653.
Competing interests: E.D.S. is a cofounder of Rumi Scientific.
Read more:
Self-organization of stem cells into embryos: A window on early ...
- Concise Review: Human Embryonic Stem CellsWhat Have We Done? What Are ... - December 22nd, 2024
- Cedars-Sinai, UCSF Experts Steer the Development of Stem Cells to Regenerate and Repair Organs - Cedars-Sinai - December 22nd, 2024
- Stem cells head to the clinic: treatments for cancer, diabetes and Parkinsons disease could soon be here - Nature.com - December 20th, 2024
- Scientists steer the development of stem cells to regenerate and repair organs - Phys.org - December 20th, 2024
- Scientists reprogram elephant stem cells to revive the woolly mammoth - The Brighter Side of News - December 19th, 2024
- Timely TGF signalling inhibition induces notochord - Nature.com - December 19th, 2024
- Embryonic stem cells | UCLA BSCRC - December 17th, 2024
- A seventh case of HIV cure reported at AIDS 2024 - December 15th, 2024
- First case of HIV cure in a woman after stem cell transplantation ... - December 15th, 2024
- WHO issues new recommendations on human genome editing for the ... - December 15th, 2024
- Human genome editing - World Health Organization (WHO) - December 15th, 2024
- Living mouse created with stem cells that predate animals - Earth.com - December 7th, 2024
- Ageing of stem cells reduces their capacity to form tumours - Nature.com - December 5th, 2024
- Genes Older Than Animal Life Itself Were Inserted Into Mice. Here's What Happened. - ScienceAlert - December 5th, 2024
- DEAD-box RNA helicase 10 is required for 18S rRNA maturation by controlling the release of U3 snoRNA from pre-rRNA in embryonic stem cells -... - November 29th, 2024
- Report calls for legislation to bolster governance of stem cell-based embryo models - Durham University - November 29th, 2024
- Researchers shed new light on role of DNA in human development - Kalinga TV - November 26th, 2024
- SCIENCE NOTEBOOK | Good News About Hole in the Antarctics Ozone Layer, and New Hope for Patients with LSCD - Frontline - November 26th, 2024
- What Stem Cell Treatments Canand CantDo - AOL - November 22nd, 2024
- Human embryonic stem cells: Derivation, culture, and differentiation: A ... - November 22nd, 2024
- Gain of 1q confers an MDM4-driven growth advantage to undifferentiated and differentiating hESC while altering their differentiation capacity -... - November 22nd, 2024
- From head to tail: How cells can behave autonomously during early development - Phys.org - November 20th, 2024
- Cooperative role of LSD1 and CHD7 in regulating differentiation of mouse embryonic stem cells - Nature.com - November 18th, 2024
- The emergence of Sox and POU transcription factors predates the origins of animal stem cells - Nature.com - November 18th, 2024
- Genes of ancient animal relatives used to grow a mouse: Study reveals hidden history of stem cells - Phys.org - November 18th, 2024
- MD Anderson Cancer Center unveils cell therapy research institute that will work with biotech, pharma - Fierce Biotech - November 12th, 2024
- Stem cell transplantation extends the reproductive life span of naturally aging cynomolgus monkeys - Nature.com - November 10th, 2024
- Embryonic stem cells - PMC - November 8th, 2024
- Thermo Fisher and Novo Nordisk Foundation Cellerator Unite to Revolutionize Cell Therapy Manufacturing - Healthcare Digital - November 8th, 2024
- RMS Sponsors the 5th Summit on Stem Cell Derived Islets - The Manila Times - October 30th, 2024
- Differentiation fate of a stem-like CD4 T cell controls immunity to cancer - Nature.com - October 30th, 2024
- Stemness and ROS: Redox Signaling and Regulation in Stem Cell Biology - Frontiers - October 24th, 2024
- Now its getting bloody in cardiac organoids - Nature.com - October 18th, 2024
- Embryonic stem cells - PMC - National Center for Biotechnology Information - October 15th, 2024
- They Were Made Without Eggs or Sperm. Are They Human? - The Atlantic - October 15th, 2024
- A novel investigation of NANOG and POU5F1 associations in the pluripotent characterization of ES-like and epiblast cells - Nature.com - October 15th, 2024
- Researchers uncover new mechanism of stem cell differentiation linked to cancer progression - News-Medical.Net - October 14th, 2024
- Stem Cells to Reverse Diabetes, the Spread of Marburg Virus and Map of a Fruit Fly Brain - Scientific American - October 14th, 2024
- Stem Cells Market Expectation Surges with Rising Demand and Changing Trends - openPR - October 11th, 2024
- How close are we to perfecting synthetic stem cells? - The Mancunion - October 10th, 2024
- Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart - Nature.com - October 10th, 2024
- Revolutionary stem cell transplant successfully closes vision-threatening holes in the eye - Study Finds - October 4th, 2024
- Early human development and stem cell-based human embryo models - October 4th, 2024
- No partner, no problem: How people in the future might be able to have children with themselves - RNZ - October 4th, 2024
- Californias Billion-Dollar Stem Cell Initiatives End In Failure OpEd - Eurasia Review - October 4th, 2024
- The Future Of Stem Cell Therapy With Dr Adeel Khan - Style Magazines - October 4th, 2024
- New Study Mapping Stem Cells Reveals Molecular Choreography Behind ... - September 30th, 2024
- Stem Cell Research at Johns Hopkins Institute of Basic Biomedical ... - September 30th, 2024
- Zack Wang , PhD - Hopkins Medicine - September 30th, 2024
- Jennifer Hartt Elisseeff , PhD - Hopkins Medicine - September 30th, 2024
- Dr. Elias Zambidis, MD, PhD - Baltimore, MD - Pediatric Cellular ... - September 30th, 2024
- Alan David Friedman , MD - Hopkins Medicine - September 30th, 2024
- Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research - Nature.com - September 30th, 2024
- Human Embryonic Stem Cells Market Insights and Growth Trends: Leading Players and Future Projections to 2031 - WhaTech - September 26th, 2024
- Zac Efron says stem cell therapy helped him heal from The Iron Claw injuries - Daily Mail - September 25th, 2024
- The Role of Stem Cell Therapy in the Future of Personalized Medicine - HIT Consultant - September 25th, 2024
- Stem Cell Therapy Market to Exceed $831.9 Million by 2032 with 17.2% CAGR Growth - openPR - September 14th, 2024
- Brain Builders: How Stem Cell Research Is Rewriting the Genetic Code of Mental Health - SciTechDaily - September 14th, 2024
- Pausing biological clock could give boost to lab-produced blood stem cells - Phys.org - September 10th, 2024
- Alive and Kicking: Watch this space on controversy-free stem-cell ... - September 8th, 2024
- After 25 years of hype, embryonic stem cells still don't cure for ... - September 8th, 2024
- Human embryonic stem cells: origin, properties and applications - September 8th, 2024
- Livestock embryonic stem cells for reproductive biotechniques and ... - September 8th, 2024
- Marinexcell: Our Vision Is To Create a Sustainable and Reliable Source of Seafood Products - vegconomist - the vegan business magazine - September 6th, 2024
- How cells enter the germline at the right time and place during embryonic development - MRC Laboratory of Molecular Biology - September 6th, 2024
- Diabetes took over her life, until a stem cell therapy freed her - redlakenationnews.com - August 31st, 2024
- Diabetes took over her life, until a stem cell therapy freed her - The Washington Post - August 27th, 2024
- New way to extend shelf life of blood stem cells will improve gene therapy - University of Cambridge news - August 20th, 2024
- The anti-aging tech guy is now shooting $25,000 worth of stem cells into his knees. Here's why - Quartz - August 16th, 2024
- Substrates mimicking the blastocyst geometry revert pluripotent stem cell to naivety - Nature.com - August 12th, 2024
- Delivery of stem cell therapy for Parkinsons safe in primate trial - Parkinson's News Today - August 2nd, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report - July 31st, 2024
Recent Comments